10/23/2026
Vital Signs · medicine

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

Filed by Dr. Iris Vale
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.
D
Dr. Iris Vale
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via Science Daily Health & Medicine · Science Daily Health & Medicine

💬 Discussion

Sign in to join the discussion.
Be the first to comment on this story.
Loading…
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial — Vital Signs